Navigation Links
Geisinger rheumatologists redesign osteoporosis, rheumatoid arthritis care
Date:11/16/2007

DANVILLE, PA. With the nation collectively spending about $18 billion per year on osteoporosis related bone fractures, Geisinger researchers found that streamlining the ordering process for osteoporosis bone density scans quadrupled the number of patients who received the exam.

An estimated 10 million Americans suffer from osteoporosis. Like most providers, Geisinger Health System measures the mineral content in the bones of patients who are at high-risk for osteoporosis through DXA scans.

Follow-up exams are usually needed to assess how the disease has progressed. Geisingers rheumatology department removed some of the steps involved, shifted the responsibility of ordering the exam from the patients primary care provider to the rheumatology staff and made greater use of Geisingers $80 million Electronic Health Record.

Before the change, 18% of patients received the test. After the test, 88% received the scan.

A broken bone from osteoporosis can be excruciating and hard to recover from, said Eric Newman, MD, Geisingers Rheumatology Director. Testing for osteoporosis is the first step in preventing these breaks.

Results of the study were presented at the American College of Rheumatologys annual meeting in Boston recently. Geisinger had four presentations at the meeting, the most ever for the department.

The other work included:

  • Plenary Presentation - The first in-depth study of new care recommendations that were issued by the American College of Rheumatology. Geisinger examined the records of over 1,000 patients with rheumatoid arthritis to see how many patients received certain suggested care benchmarks such as joint exams and use of medication.

Among the studys key findings was that 94% of the patients received disease modifying antirheumatic drugs, which ease pain, reduce inflammation and reduce or prevent joint damage. This was far higher than anticipated, Newman noted.

While more than 3,000 study abstracts were submitted for the meeting, this was one of just 14 studies that were accepted as plenary presentations.

  • The third study found that treatment decisions in patients with rheumatoid arthritis are altered if doctors have all of a patients data immediately in front of them in several summarizing charts, as opposed to having the information scattered throughout many pages in the Electronic Health Record and in paper files.

  • The fourth study examined how fellowship training for rheumatologists has improved significantly by adding a specific osteoporosis training curriculum.

It was an outstanding year for us, Newman said. These studies reflect our staffs talent and commitment to delivering the best care to our patients.


'/>"/>

Contact: Justin Walden
jawalden@geisinger.edu
570-271-8083
Geisinger Health System
Source:Eurekalert

Related medicine news :

1. UT rheumatologists discover 2 genes related to disabling form of arthritis
2. Biologic treatment for rheumatoid arthritis and the risk of cancer
3. Genes Boost Risk for Rheumatoid Arthritis, Lupus
4. The genes involved in rheumatoid arthritis identified
5. Genome Area Linked to Rheumatoid Arthritis
6. Meditation therapy for rheumatoid arthritis patients
7. Meditation May Help Rheumatoid Arthritis Sufferers
8. Researchers identify genes that increase rheumatoid arthritis risk
9. The widening mortality gap between people with rheumatoid arthritis and the general population
10. Rheumatoid Arthritis Death Rate Unchanged
11. Drugs Can Ease Juvenile Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... Experimentation involving human stem cells (HSCs) ... to its potential for revolutionizing human disease treatment. There are multiple HSC platforms ... cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, but what ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... TopConsumerReviews.com recently ... Mobility Scooters . , Mobility Scooters give freedom to people who need help ... Still others may be facing a long period of rehabilitation after an illness or ...
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... CRANBURY, N.J. , Dec. 5, 2016 /PRNewswire/ ... pharmaceutical company, today presented data from two Phase ... poster sessions at the 58th annual meeting of ... San Diego, California . The two ... patients with acute myeloid leukemia (AML) and T-cell ...
(Date:12/5/2016)... Dec. 5, 2016   Lexicon Pharmaceuticals, Inc. ... from a Phase 2 clinical study of sotagliflozin, a ... collaboration with JDRF, the leading global organization funding type ... Phase 2 clinical trial, which randomized a total of ... once-daily 400 mg dose of sotagliflozin compared to a ...
(Date:12/5/2016)... 5, 2016  Sharn Anesthesia Inc. announced today that ... distribution partner for Salter Labs.  The company also received ... recognition of outstanding sales performance. Salter Labs ... anesthesia care, including the market gold standard ECO 2 ... distributor of the Parker Flex-Tip® Endotracheal Tube, which is ...
Breaking Medicine Technology: